前沿生物-U
(688221)
| 流通市值：78.40亿 | | | 总市值：78.40亿 |
| 流通股本：3.75亿 | | | 总股本：3.75亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 187,601,398.98 | 170,344,359.37 | 97,399,221.59 | 167,678,148.86 |
| 交易性金融资产 | 542,118,782.54 | 542,794,210.66 | 594,745,179.92 | 559,583,896.87 |
| 应收票据及应收账款 | 43,290,858.04 | 58,493,284.52 | 62,906,181.25 | 46,132,395.99 |
| 其中：应收票据 | 4,911,211 | - | 3,621,455 | 1,000,000 |
| 应收账款 | 38,379,647.04 | 58,493,284.52 | 59,284,726.25 | 45,132,395.99 |
| 预付款项 | 19,522,702.36 | 10,072,621.59 | 10,726,540.36 | 16,998,886.48 |
| 其他应收款合计 | 134,150,238.41 | 133,600,024.86 | 219,289,873.77 | 215,792,137.23 |
| 其中:应收利息 | 9,795,211.7 | 8,615,143.71 | 8,539,744.86 | 6,283,593.48 |
| 存货 | 78,198,818.37 | 66,620,799.93 | 48,509,627.4 | 62,057,129.47 |
| 其他流动资产 | 282,935,017.15 | 22,892,868.97 | 22,324,401.94 | 8,477,294.13 |
| 流动资产合计 | 1,287,817,815.85 | 1,004,818,169.9 | 1,055,901,026.23 | 1,076,719,889.03 |
| 非流动资产: | | | | |
| 长期股权投资 | 20,694,232.45 | 21,265,016.14 | 17,602,634.93 | 24,431,577.87 |
| 固定资产 | 416,298,931.21 | 422,408,594.02 | 426,669,436.06 | 236,845,758.29 |
| 在建工程 | 381,946.91 | 405,221.24 | 2,362,123.9 | 172,451,596.12 |
| 使用权资产 | 703,573.63 | 415,604.45 | 326,966.04 | 326,966.04 |
| 无形资产 | 122,177,815.7 | 127,553,508.18 | 132,938,433.63 | 138,323,359.1 |
| 长期待摊费用 | 2,036,115.67 | 1,444,400.18 | 1,589,768.73 | 1,735,137.31 |
| 其他非流动资产 | 340,500 | - | - | 12,393,614.64 |
| 非流动资产合计 | 562,633,115.57 | 573,492,344.21 | 581,489,363.29 | 586,508,009.37 |
| 资产总计 | 1,850,450,931.42 | 1,578,310,514.11 | 1,637,390,389.52 | 1,663,227,898.4 |
| 流动负债: | | | | |
| 短期借款 | 285,316,201.01 | 249,713,438.74 | 226,956,380.54 | 185,985,522.54 |
| 应付票据及应付账款 | 30,807,252.17 | 47,060,713.89 | 29,840,778.08 | 43,431,960.17 |
| 其中：应付票据 | - | - | - | 3,699,264.08 |
| 应付账款 | 30,807,252.17 | 47,060,713.89 | 29,840,778.08 | 39,732,696.09 |
| 预收款项 | 20,000 | 35,000 | 50,000 | - |
| 合同负债 | 12,587,669.3 | 1,780,595.62 | 1,820,247.11 | 1,852,230.77 |
| 应付职工薪酬 | 10,625,663.17 | 18,523,508.13 | 18,609,905.7 | 15,220,943.86 |
| 应交税费 | 1,151,914.53 | 932,667.9 | 870,059.75 | 821,774.11 |
| 其他应付款合计 | 9,682,268.65 | 15,945,990.92 | 18,352,384.63 | 15,732,932.73 |
| 一年内到期的非流动负债 | 13,534,000 | 76,333,413.16 | 93,896,507.62 | 110,481,155.44 |
| 其他流动负债 | 56,915.99 | 14,010.46 | 25,090.52 | 28,023.05 |
| 流动负债合计 | 363,781,884.82 | 410,339,338.82 | 390,421,353.95 | 373,554,542.67 |
| 非流动负债: | | | | |
| 长期借款 | 172,505,891 | 82,855,241.19 | 53,487,600 | 53,936,000 |
| 租赁负债 | 236,471.41 | - | - | - |
| 长期应付款 | 147,626,540.64 | 147,626,540.64 | 147,626,540.64 | 125,630,300 |
| 预计负债 | 1,637,918.07 | 1,587,196.45 | 2,352,034.28 | - |
| 递延收益 | 56,384,350.96 | 59,033,405.01 | 61,982,459.06 | 66,131,513.11 |
| 非流动负债合计 | 378,391,172.08 | 291,102,383.29 | 265,448,633.98 | 245,697,813.11 |
| 负债合计 | 742,173,056.9 | 701,441,722.11 | 655,869,987.93 | 619,252,355.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 374,578,653 | 374,578,653 | 374,578,653 | 374,578,653 |
| 资本公积 | 2,730,761,484.95 | 2,726,786,932.91 | 2,723,191,887.05 | 2,723,191,887.05 |
| 其他综合收益 | 78,916.5 | 38,140.2 | 40,289.69 | 39,515.33 |
| 未分配利润 | -1,997,141,179.93 | -2,224,534,934.11 | -2,116,290,428.15 | -2,053,834,512.76 |
| 归属于母公司股东权益合计 | 1,108,277,874.52 | 876,868,792 | 981,520,401.59 | 1,043,975,542.62 |
| 股东权益合计 | 1,108,277,874.52 | 876,868,792 | 981,520,401.59 | 1,043,975,542.62 |
| 负债和股东权益合计 | 1,850,450,931.42 | 1,578,310,514.11 | 1,637,390,389.52 | 1,663,227,898.4 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |